Role of molecular examinations in qualification to first line treatment with erlotinib in NSCLC patients based on EURTAC study results Journal title: OncoReview Authors: Paweł Krawczyk Subject(s): Medicine, Cardiology, Internal Medicine, Oncology, Cardiac & Cardiovascular Systems
Znaczenie badań molekularnych w kwalifikacji do terapii I linii erlotynibem chorych na NDRP na podstawie wyników badania EURTAC Journal title: OncoReview Authors: Paweł Krawczyk Subject(s): Medicine, Cardiology, Internal Medicine, Oncology, Cardiac & Cardiovascular Systems
